SERENA NGAN: Open Payments
NPI 1962014621 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 19 payments from 7 companies in 2025. Trend: 2023 $41 · 2024 $99 · 2025 $551
Food & beverage: $451Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 10 | $293 |
| Gilead Sciences, Inc. | 1 | $100 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Caris MPI, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| EMD Serono, Inc. | 1 | $14 |
Products named: Enhertu, Trodelvy, KEYTRUDA, MI CANCER SEEK, JEMPERLI, TAGRISSO.
Industry payments across NJ — which companies pay providers there.
